Affiliation: University of Munich
- Biological marker candidates of Alzheimer's disease in blood, plasma, and serumPhiline Schneider
Department of Psychiatry, Ludwig Maximilian University, Alzheimer Memorial Center, Munich, Germany
CNS Neurosci Ther 15:358-74. 2009..The status and emerging perspectives on hypothesis and exploratory-based candidate biomarkers derived from blood, plasma, and serum are reviewed and discussed...
- Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairmentPhiline Schneider
Alzheimer Memorial Center, Department of Psychiatry, Klinikum Grosshadern, Ludwig Maximilian University, Munich, Germany
Biol Psychiatry 70:145-51. 2011..Midregional proatrial natriuretic peptide (MR-proANP), an inactive surrogate molecule of the mature atrial natriuretic peptide, is related to circulatory function and hypertension...
- Laboratory reference values for healthy adults from southern TanzaniaElmar Saathoff
Abteilung fuer Infektions und Tropenmedizin, Klinikum der Universitaet Muenchen, Munich, Germany
Trop Med Int Health 13:612-25. 2008..To define and discuss reference ranges for commonly determined laboratory parameters in healthy adults from southern Tanzania...
- Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot studyVerena C Buschert
Department of Psychiatry Ludwig Maximilians University, Munich, Germany
J Alzheimers Dis 25:679-94. 2011..In contrast, AD patients showed no significant benefit from intervention. The findings in this small sample support the use of the intervention in larger scales studies with an extended follow-up period to determine long-term effects...